These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Crohn's disease - treatment with biological medication. Zaltman C; Amarante H; Brenner MM; Costa MHM; Flores C; Leal RF; Grain JFS; Zeroncio M Rev Assoc Med Bras (1992); 2019 May; 65(4):554-567. PubMed ID: 31066809 [TBL] [Abstract][Full Text] [Related]
3. Use of daratumumab in patients with amyloidosis. Anzai A; Utino A; Katayama H; Spir IAZ; Lemos MA; Anhesini M; Tiezzi OS; Spir PRN; Otani P; Bernardo WM Rev Assoc Med Bras (1992); 2020 Nov; 66(11):1468-1471. PubMed ID: 33295391 [TBL] [Abstract][Full Text] [Related]
4. Moderate to severe plaque psoriasis - treatment with drugs of the classic scheme. Arnone M; Carvalho AVE; Takahashí MDF; Bernardo WM Rev Assoc Med Bras (1992); 2019 May; 65(4):530-534. PubMed ID: 31066805 [TBL] [Abstract][Full Text] [Related]
5. Psoriasis in moderate grave plaque - immunobiological treatment. Arnone M; Carvalho AVE; Takahashi MDF; Bernardo WM Rev Assoc Med Bras (1992); 2019 May; 65(4):493-508. PubMed ID: 31066801 [TBL] [Abstract][Full Text] [Related]
6. Advanced melanoma in adults: Pembrolizumab as a treatment option. Silvinato A; Bernardo WM; Floriano I Rev Assoc Med Bras (1992); 2020 May; 66(2):100-107. PubMed ID: 32428140 [TBL] [Abstract][Full Text] [Related]
7. Deep brain stimulation in parkinson disease. Bernardo WM; Rubira C; Silvinato A Rev Assoc Med Bras (1992); 2019 May; 65(4):541-546. PubMed ID: 31066807 [TBL] [Abstract][Full Text] [Related]
8. Decompensated congestive heart failure - treatment with levosimendan. Buzzini RF; Silvinato A; Floriano I; Bernardo WM; Almeida GR Rev Assoc Med Bras (1992); 2019 May; 65(4):524-529. PubMed ID: 31066804 [TBL] [Abstract][Full Text] [Related]
9. Sexually transmitted infections - laboratory diagnosis. Hachul M; Medeiros MVV; Simões R; Bernardo WM Rev Assoc Med Bras (1992); 2019 Jul; 65(6):745-754. PubMed ID: 31340297 [TBL] [Abstract][Full Text] [Related]
10. Comparative efficacy of golimumab, infliximab, and adalimumab for moderately to severely active ulcerative colitis: a network meta-analysis accounting for differences in trial designs. Thorlund K; Druyts E; Toor K; Mills EJ Expert Rev Gastroenterol Hepatol; 2015 May; 9(5):693-700. PubMed ID: 25763862 [TBL] [Abstract][Full Text] [Related]
13. Cost per remission and cost per response with infliximab, adalimumab, and golimumab for the treatment of moderately-to-severely active ulcerative colitis. Toor K; Druyts E; Jansen JP; Thorlund K J Med Econ; 2015 Jun; 18(6):437-46. PubMed ID: 25629655 [TBL] [Abstract][Full Text] [Related]
14. Depression in the workplace: screening and treatment. ; Domingos Neto J; Myung E; Murta G; Vieira A; Lima PR; Lessa LA; Bernardo WM Rev Assoc Med Bras (1992); 2019 Mar; 65(3):295-315. PubMed ID: 30994824 [TBL] [Abstract][Full Text] [Related]
15. Chronic pain treatment with spinal cord neurostimulation. ; ; Cukiert A; Reis AMD; Almeida AS; Simões RDS; Buzzini RF; Bernardo WM Rev Assoc Med Bras (1992); 2018 Apr; 64(4):299-306. PubMed ID: 30133606 [TBL] [Abstract][Full Text] [Related]
16. [Comparison of Treatment Guidelines for Ulcerative Colitis: Role of Biologics]. Bae JH; Yang DH Korean J Gastroenterol; 2018 Apr; 71(4):192-195. PubMed ID: 29684967 [TBL] [Abstract][Full Text] [Related]